Delivery Order SPE2DB24D9238-SPE2DB24FDQND

Award Date 8/28/24
Potential Completion Date 9/19/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,224.44 firm fixed-price delivery order is for the provision of VABYSMO 6 MG/0.05 ML VIAL 0.05ML pharmaceutical products. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,112.22 firm fixed-price delivery order is for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with an ultimate completion date of November 7, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,224.44 firm fixed-price delivery order is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a period of performance through May 20, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,458.40, is a firm fixed-price delivery order for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML. The contract has an ultimate completion date of February 3, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, which is a large Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. This delivery order, valued at $3,112.22, is for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML. The contract is a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $46,683.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with an ultimate completion date of August 9, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $18,673.32 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, under the SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999, is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML medication to support the recurring pharmaceutical needs of Department of Defense (DoD) healthcare facilities worldwide. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,780.55 contract is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
This is a $6,224.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, with a period of performance through November 7, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,224.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a period of performance through April 2, 2024. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB, valued up to...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB24FDQND
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,668.33 firm fixed-price delivery order is for the pharmaceutical product VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a delivery deadline of September 19, 2024.

DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities worldwide. This contract award is not designated as a set-aside.

Generated 11/27/24, 9:17 AM